Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Millipore Launches Progenitor Cell-Enriched Primary Human Epithelial Cell Cultures

Published: Friday, April 18, 2008
Last Updated: Friday, April 18, 2008
Bookmark and Share
According to Company, these primary cell cultures are designed to provide an enriched population of progenitor cells from skin, cornea, and bladder epithelia.

Millipore Corporation has announced the release of a new range of primary human epithelial cells. Developed by CELLnTEC Advanced Cell Systems, these epithelial cell cultures are made available by Millipore as part of a partnership agreement signed in 2006.

Supplied as complete kits including specialized media for their propagation, these primary cell cultures provide an enriched population of progenitor cells from skin, cornea, and bladder epithelia. These unique cells have significant applications for all medical research laboratories studying epithelial disease, regenerative medicine, cancers of these tissues, or basic biology of these tissues’ epithelia.

The new cells display optimal modeling and morphology, plus extended longevity due to their isolation in CELLnTEC’s Progenitor Cell Targeted (PCT) media formulations. PCT culture media are developed to specifically mimic the environment of the stem cell niche, and significantly increase isolation efficiency, progenitor cell enrichment and longevity of epithelial cell cultures.

Primary progenitor cells in kits with optimized media are a highly convenient solution for many researchers. Laboratories lacking either access to tissue or the expertise to conduct the difficult isolation of primary epithelial cells may now extend the reach of their discoveries. By providing pre-isolated, long-lived progenitor cells, Millipore and CELLnTEC are enabling the research community to expand its research potential.

Millipore has evolved from a high performance filtration products and services company into a leading provider of tools and services and a key partner of choice for Life Science customers. We’ve transformed ourselves through R&D investment, organic growth, and acquisitions such as Chemicon, Upstate, Linco, Celliance, Newport Bio Systems, NovAseptic AB and MicroSafe.

The integrated Millipore offers more innovative technologies and stronger application support to streamline processes and provide consistently reliable results. The expert scientists in our Life Sciences business unit understand the complexity of Life Science research and can support our customers in their most difficult challenges in cell biology, stem cells, protein research, and cell signaling.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Cellular Reprogramming – What the Future Holds
Advancements in cellular reprogramming are coming at a furious pace. Along with these scientific breakthroughs come new opportunities for the development of therapeutics, disease modeling, drug screening, and new pathways to personalized medicine.
Friday, July 23, 2010
Millipore Expands Drug Discovery and Development Services with BioAnaLab Acquisition
Acquisition extends Millipore’s biopharmaceutical services offering to European market.
Tuesday, August 11, 2009
Millipore Opens new Bioprocess Manufacturing Facility in Massachusetts
New facility will produce company’s Mobius® single-use product line used for biopharmaceutical manufacturing technologies.
Wednesday, June 10, 2009
Millipore and UMass Lowell Dedicate the Millipore Process Development Laboratory
Millipore announced the opening of the Millipore Corporation Process Development Laboratory in partnership with the university.
Friday, April 10, 2009
Millipore Announces Technology Acquisition to Strengthen Drug Discovery Product Offering
The purchase of Epitome Biosystems’ EpiTag™ technology assets will accelerate development of multiplex immunoassays for cell signaling.
Monday, March 02, 2009
Millipore Extends Exclusive License Agreement with University of Dundee
The ongoing collaboration will bring novel cell signaling tools and services to life science researchers worldwide.
Friday, October 10, 2008
ReNcell® VM Neural Stem Cell Line Models Parkinson’s Disease
Milipore announces the publication of a new discovery derived from its ReNcell VM neural stem cell line.
Tuesday, July 22, 2008
Millipore Unveils Expanded Drug Discovery Development Facility
The $3.4 million expansion will enable Millipore to keep pace with the growth of its worldwide drug discovery and development business.
Monday, June 30, 2008
Millipore Launches Antibody Learning Center
The web tool is designed for navigating company’s antibody portfolio and planning efficient workflows for immunodetection in protein research.
Wednesday, April 16, 2008
Millipore Corporation and Novozymes Form Strategic Alliance to Supply Animal-Free Cell Culture Supplements for Bioprocessing
Alliance will accelerate launch of new animal-free supplements and provide customers with a source of high performance cell culture products.
Tuesday, December 18, 2007
Frost & Sullivan Commends Millipore’s Success in Developing Mammalian Gene Expression UCOE Technology
Millipore announced to be the recipient of the 2007 Frost & Sullivan Technology Innovation of the Year Award in the U.S. Drug Discovery Technologies market.
Monday, December 10, 2007
Millipore Announces Stem Cell Tested Initiative
Millipore’s Stericup with Express PLUS membrane is the first available under this initiative.
Wednesday, December 05, 2007
Millipore Launches new Website
Improved functions include product information, ordering and support.
Wednesday, October 31, 2007
Millipore Corporation Announces new ReNcell® Data from Collaboration with ReNeuron
Millipore releases new data concerning its ReNcell neural stem cell lines at the ISSCR meeting in Cairns, Australia on June 20, 2007.
Thursday, June 21, 2007
Millipore Announces Kinase Screening Agreement with Johnson & Johnson Pharmaceutical Research & Development
J&JPRD to supply potential protein kinase inhibitors for kinase selectivity profiling against Millipore's panel of 252 protein and lipid kinases.
Wednesday, January 17, 2007
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos